A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-927 With ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Cancer|Advanced Solid Tumors|Triple-Negative Breast Cancer (TNBC)|Non-small-cell-lung-cancer (NSCLC)|Metastatic Solid Tumors
Interventions: DRUG: ABBV-927|DRUG: ABBV-368|DRUG: ABBV-181|DRUG: Carboplatin|DRUG: Nab-paclitaxel
Sponsor: AbbVie